Aydin S The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus. Peptides. 2010 Dec;31(12):2236-40. doi: 10.1016/j.peptides.2010.08.021. Epub 20
Cesur G, Ozguner F, Yilmaz N, Dundar B The relationship between ghrelin and adiponectin levels in breast milk and infant serum and growth of infants during early postnatal life. J Physiol Sci. 2012 May;62(3):185-90. doi: 10.1007/s12576-012-0193-z. Epub 2
Chamberlain C, Banks E, Joshy G, Diouf I, Oats JJ, Gubhaju L, Eades S Prevalence of gestational diabetes mellitus among Indigenous women and comparison with non-Indigenous Australian women: 1990-2009. Aust N Z J Obstet Gynaecol. 2014 Oct;54(5):433-40. doi: 10.1111/ajo.12213. Epub 2014 Apr 29.
Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J. 2015 Mar;19(3):635-42. doi: 10.1007/s10995-014-1553-5.
Doneray H, Orbak Z, Yildiz L The relationship between breast milk leptin and neonatal weight gain. Acta Paediatr. 2009 Apr;98(4):643-7. doi: 10.1111/j.1651-2227.2008.01192.x. Epub 2009 Jan 7.
Dosch HM, Becker DJ Infant feeding and autoimmune diabetes. Adv Exp Med Biol. 2002;503:133-40. Review.
Fields DA, Demerath EW Relationship of insulin, glucose, leptin, IL-6 and TNF-a in human breast milk with infant growth and body composition. Pediatr Obes. 2012 Aug;7(4):304-12. doi: 10.1111/j.2047-6310.2012.00059.x. Epub 2012 May 10.
Hansen GH, Niels-Christiansen LL, Danielsen EM Leptin and the obesity receptor (OB-R) in the small intestine and colon: a colocalization study. J Histochem Cytochem. 2008 Jul;56(7):677-85. doi: 10.1369/jhc.2008.950782. Epub 2008 Apr 14.
Ley SH, Hanley AJ, Sermer M, Zinman B, O'Connor DL Associations of prenatal metabolic abnormalities with insulin and adiponectin concentrations in human milk. Am J Clin Nutr. 2012 Apr;95(4):867-74. doi: 10.3945/ajcn.111.028431. Epub 2012 Feb 29.
Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr. 2006 Nov;84(5):1043-54. Review. Erratum in: Am J Clin Nutr. 2012 Mar;95(3
Savino F, Fissore MF, Liguori SA, Oggero R Can hormones contained in mothers' milk account for the beneficial effect of breast-feeding on obesity in children? Clin Endocrinol (Oxf). 2009 Dec;71(6):757-65. doi: 10.1111/j.1365-2265.2009.03585.x. Epub 2009
Schack-Nielsen L, Michaelsen KF Breast feeding and future health. Curr Opin Clin Nutr Metab Care. 2006 May;9(3):289-96. Review.
Schuster S, Hechler C, Gebauer C, Kiess W, Kratzsch J Leptin in maternal serum and breast milk: association with infants' body weight gain in a longitudinal study over 6 months of lactation. Pediatr Res. 2011 Dec;70(6):633-7. doi: 10.1203/PDR.0b013e31823
Weyermann M, Brenner H, Rothenbacher D Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study. Epidemiology. 2007 Nov;18(6):722-9.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.